Is Salesforce a Value Trap or the Contrarian Trade of the Year?

Something odd is happening with Salesforce. The company just posted its fifth consecutive earnings beat. Revenue grew 13% year-over-year. Free cash flow hit $6.6 billion in a single quarter. Non-GAAP operating margin reached a record 34.8%. And the stock is still down 33% in 2026, making it the worst-performing component in the Dow Jones Industrial Average by a wide margin.

That disconnect is not an accident. It is the central debate happening in institutional investment committees right now.

The question is this: is Salesforce a deeply mispriced business being written off by a market that has it wrong, or is the market correctly sensing that the entire seat-based enterprise software model is about to be disrupted from the inside by AI agents that eventually replace the humans who buy those seats?

Why Institutional Investors Are Focused on This

Two things happened in July that made the Salesforce debate impossible to ignore.

First, IBM pre-announced a massive Q2 miss. IBM CEO Arvind Krishna said the spending shift accelerated unexpectedly during the final weeks of June as customers rushed to secure hardware before anticipated price increases, and that enterprises were delaying software purchases while prioritizing investments viewed as essential for competing in the AI era. IBM’s stock fell 25%, its steepest single-day decline in records going back to 1968, worse than the 23.7% drop it took on Black Monday in October 1987. Shares of Microsoft, ServiceNow, Salesforce, and Intuit all fell between 2% and 5% as investors reassessed whether the AI investment cycle is cannibalizing spending on traditional enterprise software.

Second, and almost simultaneously, Guggenheim analyst John DiFucci upgraded the stock to Buy with a $228 target on July 1, saying the AI doom scenario priced into Salesforce stock in 2026 is “misaligned with reality.” Shares jumped about 5% on the day.

Two credible institutional signals, pointing in opposite directions, within weeks of each other. That is exactly the kind of setup that defines the most interesting moments in markets.

The Bull Case

Start with the numbers, because they are genuinely hard to dismiss.

Q1 FY2027 revenue of $11.13 billion grew 13% year over year, non-GAAP EPS of $3.88 jumped 50%, and non-GAAP operating margin hit a record 34.8%, a 250-basis-point expansion. Q1 free cash flow of $6.6 billion on $11.1 billion in revenue represents an approximately 60% FCF margin for the quarter. Even adjusting for seasonal billing patterns, that is an extraordinary number for a company the market is treating as structurally impaired.

Then there is Agentforce. Agentforce annual recurring revenue crossed $1.2 billion, up 205% year over year, making it the fastest-scaling AI product line any enterprise SaaS company has reported in 2026. 3.8 billion Agentic Work Units delivered in a single quarter, and 28.6 trillion tokens processed cumulatively, are not marketing statistics. They are consumption infrastructure metrics that imply meaningful enterprise adoption at production scale.

The customer mix matters here. More than 50% of Agentforce and Data 360 bookings during Q1 came from existing customers expanding deployments. That is not a company selling something new to strangers. That is a company monetizing deeper into its own installed base, which is a much more durable revenue dynamic.

On valuation, Salesforce trades at roughly 12 to 13 times forward earnings, among the cheapest the stock has been in years and well below its historical trading range. Normalized earnings have grown from around $5 in 2021 to $12.52 in fiscal 2026, and consensus projects acceleration toward around $14 in fiscal 2027 and nearly $23 by 2031. A business compounding earnings at that rate does not typically trade at 12 times forward earnings unless the market believes the earnings are about to stop.

The Bear Case

The bear case is not that Salesforce is a bad business. It is that the business model itself is entering a structural transition it may not survive at current scale.

For 25 years, Salesforce built one of the most durable businesses in enterprise software by selling seats, one license, one human, one monthly bill. That model made the company a $300 billion giant at its peak. Now Wall Street is asking whether the AI agents Salesforce is selling could eventually replace the very humans paying for those seats.

The IBM warning hardened this fear into something more concrete. IBM was effectively telling the market that AI expenditure is not always an additional layer placed neatly on top of existing technology budgets. In some organizations, it is forcing difficult trade-offs within those budgets. This is the clearest public signal yet that the AI boom is cannibalizing traditional software budgets. CIOs are not adding money to the pile. They are reallocating it.

Slight tangent, but it matters: Salesforce and ServiceNow, both providers of enterprise sales, HR, and IT management tools, have seen their market capitalizations shrink by about one-third in 2026, making them among the worst performers in the S&P 500. In stark contrast, the Philadelphia Semiconductor Index is still up 68% for the year. That divergence tells you exactly what the market currently believes about who wins and who loses from the AI budget reallocation.

The bear case works if the IBM thesis is correct and enterprises are reallocating software budgets toward GPUs and hyperscaler consumption. In that scenario, seat-based CRM revenue stalls, Agentforce cannibalizes rather than expands, and the noncurrent debt from the buyback becomes a real drag on valuation.

What the Evidence Shows

The honest read is that both cases contain real evidence, which is what makes this debate genuinely difficult.

The bulls have the numbers. The drawdown is strange given the earnings picture. Q1 FY27 delivered EPS of $3.88 against a $3.13 consensus, revenue of $11.13 billion up 13.3% year-over-year, and marked the fifth straight quarterly EPS beat. The market sold it anyway.

The bears have the macro signal. IBM’s warning detonated deep-seated market fears that enterprise IT budgets are undergoing a massive shift from software to AI hardware, dragging Workday, ServiceNow, and several other software stocks into a synchronized rout.

What is less discussed is that these two things are not necessarily contradictory. Salesforce could be executing well at the company level while the category around it shifts. Agentforce ARR of $1.2 billion on an annualized basis reflects less than 3% of the company’s projected overall annual revenue. The new model is growing at 205%, but it is still too small to replace the base if the base starts shrinking. That is the math that keeps institutional investors up at night.

The Mavens’ View

The experienced investors engaging seriously with this stock are making one distinction that the broad debate tends to skip. They are separating the question of whether AI disrupts the software category from the question of whether Salesforce specifically survives that disruption better than its peers.

DiFucci’s argument at Guggenheim is worth understanding on its own terms. The stock has spent 2026 absorbing a single fear: that the AI agents Salesforce now sells will quietly retire the human seats its customers have paid for since 1999. DiFucci is not dismissing that fear. He calls AI a “significant risk.” He is arguing something narrower and more interesting: that the market has priced an extinction event into a company that is still growing double digits and generating significant cash.

If the agentic era drives consumption up rather than seats down, the cannibalization math the bears run is incomplete. That is the crux of the entire debate. And the answer is not yet visible in the data.

Over the last month, CRM has clawed back 14.5% while the S&P 500 slipped 0.62%, hinting that capitulation may be finished. That is not confirmation the bottom is in. But it suggests the most aggressive sellers may have already moved on.

What Investors Are Missing

Almost nobody is talking about what the IBM warning actually revealed about Salesforce’s relative position. IBM sells generic middleware, integration software, and mainframe systems. Salesforce sells the system of record for customer relationships, the data layer that every enterprise needs to run Agentforce agents on top of in the first place. Those are very different levels of the enterprise software stack when it comes to budget defensibility.

What’s interesting is that the companies most exposed to the IBM-style budget displacement are the ones selling software that enterprises can delay renewing. CRM data is mission-critical. You cannot pause your customer database while you build out your GPU cluster. That distinction is not showing up in the market’s current treatment of Salesforce alongside Workday and ServiceNow as interchangeable casualties.

There is also a public sector angle worth watching. Salesforce’s Public Sector Industry Cloud ARR surpassed $2 billion, up 23% year-over-year in Q1, with Public Sector Agentic Work Units up nearly 400% quarter-over-quarter. Government agencies are not reallocating their software budgets to buy GPUs. They are deploying AI agents on top of existing Salesforce infrastructure. That is a segment of the business that does not fit the IBM displacement story at all, and it barely appears in the bear case analysis circulating on institutional desks.

Stocks to Watch

• Salesforce (CRM): The obvious centerpiece. 41 out of 55 analysts covering the stock rate it a Buy or Strong Buy. The consensus target of around $245 looks reachable inside 12 months if management delivers promised second-half FY27 acceleration. At 13 times forward earnings with 200%-plus ARR growth in the AI segment, the risk-reward is asymmetric enough to matter. The path back to $245 requires Agentforce ARR continuing to scale and one clean quarter that puts the IBM-warning fears to rest.
• ServiceNow (NOW): The closest institutional comparable to Salesforce in the current debate. ServiceNow experienced the same sell-off dynamic after reporting strong earnings, and faces the same existential question about whether its workflow automation platform gets disrupted by or becomes a platform for AI agents. The distinction matters: companies that own the workflow layer may be better positioned than the bears currently assume.
• Workday (WDAY): The highest-risk name in this category. Unlike Salesforce, Workday’s HR and finance software is in a part of the enterprise stack where AI-driven consolidation could meaningfully compress seat counts. It does not have Salesforce’s customer relationship data moat, and its Agentforce-equivalent product is earlier in development. Worth watching as a read on how the market is distinguishing winners from casualties in the enterprise software displacement story.
• Veeva Systems (VEEV): The overlooked beneficiary. Veeva runs the system of record for life sciences companies, a vertical where regulatory requirements make budget displacement toward generic AI infrastructure essentially impossible. It is growing faster than Salesforce, trades at a significant premium, and that premium is arguably justified by the defensibility of its vertical. If the IBM warning accelerates the market’s interest in mission-critical versus discretionary software, Veeva is where that rotation goes.
• IBM (IBM): Worth including not as a buy but as a real-time indicator. IBM expects Q2 revenue of $17.2 billion, up just 1%, against an analyst consensus of $17.86 billion. Every quarter IBM reports, it tells the market something about whether enterprise budget displacement is accelerating or stabilizing. The read on IBM’s numbers in late July will directly shape how Salesforce and its peers trade heading into their own earnings. Watch the IBM readout as a leading signal, not a lagging one.

Here is where I land on this. The market is pricing Salesforce as if it is IBM. It is not. The data layer underneath customer relationships is not the same as a mainframe software stack. The question is whether Agentforce grows fast enough to prove that point before generalist investors give up and move on entirely.

That is not a question with a clean answer yet. Which is exactly why the trade is interesting.

— Wall St. Mavens Editorial Desk